Glaucoma
Welcome,         Profile    Billing    Logout  
 89 Companies   65 Products   65 Products   50 Mechanisms of Action   831 Trials   64145 News 


«12...700701702703704705706707708709710...720721»
  • ||||||||||  latanoprost / Generic mfg.
    Biomarker, Trial primary completion date:  Glaucoma Biomarkers (clinicaltrials.gov) -  Jan 22, 2015   
    P=N/A,  N=150, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> Dec 2015
  • ||||||||||  Trial completion, Enrollment change:  Serum Citrate in Diagnosis and Follow-up for Glaucoma (clinicaltrials.gov) -  Jan 8, 2015   
    P=N/A,  N=20, Completed, 
    Trial primary completion date: Dec 2014 --> Jun 2015 Recruiting --> Completed | N=30 --> 20
  • ||||||||||  Trial primary completion date:  Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients (clinicaltrials.gov) -  Jan 6, 2015   
    P=N/A,  N=200, Enrolling by invitation, 
    Trial primary completion date: Dec 2012 --> Dec 2015 Trial primary completion date: Dec 2012 --> Dec 2015
  • ||||||||||  ketorolac / Generic mfg., prednisolone acetate ophthalmic suspension / Generic mfg.
    Trial suspension, Trial primary completion date:  SALT: Steroids After Laser Trabeculoplasty for Glaucoma (clinicaltrials.gov) -  Dec 30, 2014   
    P4,  N=300, Suspended, 
    Recruiting --> Completed | N=126 --> 169 | Trial primary completion date: Dec 2014 --> Sep 2014 Recruiting --> Suspended | Trial primary completion date: Sep 2014 --> Sep 2015
  • ||||||||||  Trial completion, Enrollment change:  STR_FN: Structure Function Correlation in Primary Open Angle Glaucoma (clinicaltrials.gov) -  Dec 30, 2014   
    P=N/A,  N=130, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Dec 2014 Recruiting --> Completed | N=200 --> 130
  • ||||||||||  Helios ocular insert (bimatoprost sustained release insert) / AbbVie
    Trial completion, Enrollment change, Trial primary completion date:  A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension (clinicaltrials.gov) -  Dec 19, 2014   
    P1,  N=14, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=20 --> 14 | Trial primary completion date: Mar 2014 --> Jun 2014
  • ||||||||||  Trial primary completion date:  SOLX Gold Shunt for Refractory Glaucoma (clinicaltrials.gov) -  Dec 17, 2014   
    P3,  N=60, Active, not recruiting, 
    Recruiting --> Completed | N=20 --> 14 | Trial primary completion date: Mar 2014 --> Jun 2014 Trial primary completion date: Sep 2014 --> Dec 2015
  • ||||||||||  Trial completion, Trial primary completion date:  Neurovascular Coupling in Eyes of Glaucoma Patients (clinicaltrials.gov) -  Dec 17, 2014   
    P=N/A,  N=100, Completed, 
    Trial primary completion date: Sep 2014 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
  • ||||||||||  latanoprost / Generic mfg., dorzolamide/timolol / Generic mfg.
    Trial completion, Trial primary completion date, Head-to-Head:  Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma (clinicaltrials.gov) -  Dec 13, 2014   
    P=N/A,  N=44, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Feb 2012 --> Oct 2014
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Safety Study of Latanoprost Slow Release Insert (clinicaltrials.gov) -  Dec 9, 2014   
    P1,  N=12, Terminated, 
    Active, not recruiting --> Completed N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts.
  • ||||||||||  Phase classification:  Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (clinicaltrials.gov) -  Dec 9, 2014   
    P4,  N=600, Enrolling by invitation, 
    N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts. Phase classification: P=N/A --> P4
  • ||||||||||  bamosiran (SYL040012) / PharmaMar
    Enrollment open:  SYLTAG: SYL040012, Treatment for Open Angle Glaucoma (clinicaltrials.gov) -  Dec 7, 2014   
    P2,  N=180, Recruiting, 
    N=30 --> 45 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date, HEOR:  Multicentric Observational Study on Quality of Life in Glaucoma (clinicaltrials.gov) -  Dec 6, 2014   
    P=N/A,  N=3170, Active, not recruiting, 
    Recruiting --> Completed | N=60 --> 41 Trial primary completion date: Oct 2014 --> Feb 2015
  • ||||||||||  Trial primary completion date:  Novel Glaucoma Diagnostics (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=500, Recruiting, 
    N=50 --> 12 | Recruiting --> Terminated | Trial primary completion date: Nov 2012 --> Feb 2012; short of study staff Trial primary completion date: May 2012 --> May 2017
  • ||||||||||  timolol maleate ophthalmic solution / Generic mfg., travoprost ophthalmic / Generic mfg.
    Trial initiation date:  Efficacy of Changing to DuoTrav (clinicaltrials.gov) -  Dec 5, 2014   
    P4,  N=37, Terminated, 
    Trial primary completion date: May 2012 --> May 2017 Initiation date: Oct 2012 --> Jun 2012
  • ||||||||||  Enrollment open, Trial initiation date, Biopsy:  Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=20, Recruiting, 
    Initiation date: Oct 2012 --> Jun 2012 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Dec 2014